SINO BIOLOGICAL INC

Overview

SINO BIOLOGICAL INC is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering RECOMBINANT HUMAN IL-1 / BETA IL1B PROTEIN; RECOMBINANT HUMAN IL-15 PROTEIN; RECOMBINANT HUMAN IL4 / INTERLEUKIN-4 PROTEIN; RECOMBINANT HUMAN IL7 / INTERLEUKIN 7 PROTEIN; RECOMBINANT HUMAN INTERLEUKIN-21 / IL-21 PROTEIN; SIM HF EXPRESSION MEDIUM (FOR HI5, SERUM FREE).

API / Drug Master Files

SINO BIOLOGICAL INC holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SUPERNUCLEASE(ANIMAL-FREE)Active2024-12-30
• SMM 293-TII EXPRESSION MEDIUM SERUM-FREE, COMPLETE MEDIUMActive2024-07-24
• RECOMBINANT HUMAN IL4 / INTERLEUKIN-4 PROTEINActive2023-06-27
• RECOMBINANT HUMAN IL7 / INTERLEUKIN 7 PROTEINActive2023-06-27
• RECOMBINANT HUMAN IL-15 PROTEINActive2023-06-27
• RECOMBINANT HUMAN IL-1 / BETA IL1B PROTEINActive2022-12-23
• RECOMBINANT HUMAN INTERLEUKIN-21 / IL-21 PROTEINActive2022-12-05
• SIM SF EXPRESSION MEDIUM (FOR SF9 AND SF21, SERUM FREE)Active2021-06-22
• SIM HF EXPRESSION MEDIUM (FOR HI5, SERUM FREE)Active2021-06-22
• SUPERNUCLEASEActive2021-05-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SINO BIOLOGICAL INC in our records. PharmaTek screens the full directory against live FDA enforcement data.